These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21565915)

  • 41. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome.
    Kurashima K; Takaku Y; Ohta C; Takayanagi N; Yanagisawa T; Sugita Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():479-87. PubMed ID: 27019598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.
    Domingo-Salvany A; Lamarca R; Ferrer M; Garcia-Aymerich J; Alonso J; Félez M; Khalaf A; Marrades RM; Monsó E; Serra-Batlles J; Antó JM
    Am J Respir Crit Care Med; 2002 Sep; 166(5):680-5. PubMed ID: 12204865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease.
    Nishimura K; Oga T; Ikeda A; Hajiro T; Tsukino M; Koyama H
    J Asthma; 2008 Sep; 45(7):615-20. PubMed ID: 18773337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hoover's sign is a predictor of airflow obstruction severity and is not related to hyperinflation in chronic obstructive pulmonary disease.
    Bruyneel M; Jacob V; Sanida C; Ameye L; Sergysels R; Ninane V
    Eur J Intern Med; 2011 Dec; 22(6):e115-8. PubMed ID: 22075295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health-related quality of life and functional status in end-stage COPD: a longitudinal study.
    Habraken JM; van der Wal WM; Ter Riet G; Weersink EJ; Toben F; Bindels PJ
    Eur Respir J; 2011 Feb; 37(2):280-8. PubMed ID: 20530038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients--especially in patients with mild or moderate disease.
    Bratås O; Espnes GA; Rannestad T; Walstad R
    Chron Respir Dis; 2010; 7(4):229-37. PubMed ID: 21084547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measuring the effects of COPD on the patient.
    Jones P; Lareau S; Mahler DA
    Respir Med; 2005 Dec; 99 Suppl B():S11-8. PubMed ID: 16236492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis.
    Zhou Z; Zhou A; Zhao Y; Duan J; Chen P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1675-1682. PubMed ID: 29872285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients.
    Zhou QT; Mei JJ; He B; Huang SG; Shi Y; Wen FQ; Zhao MW
    Chin Med J (Engl); 2013 Jan; 126(1):11-5. PubMed ID: 23286470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.
    Manca S; Rodriguez E; Huerta A; Torres M; Lazaro L; Curi S; Pirina P; Miravitlles M
    COPD; 2014 Sep; 11(5):480-8. PubMed ID: 24832005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
    Lindberg A; Lundbäck B
    Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health status impairment and costs associated with COPD exacerbation managed in hospital.
    O'Reilly JF; Williams AE; Rice L
    Int J Clin Pract; 2007 Jul; 61(7):1112-20. PubMed ID: 17577296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD.
    Partridge MR; Miravitlles M; Ståhl E; Karlsson N; Svensson K; Welte T
    Eur Respir J; 2010 Jul; 36(1):96-104. PubMed ID: 19897551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A field test of functional status as performance of activities of daily living in COPD patients.
    Skumlien S; Hagelund T; Bjørtuft O; Ryg MS
    Respir Med; 2006 Feb; 100(2):316-23. PubMed ID: 15941658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.
    Lopez-Campos JL; Fernandez-Villar A; Calero-Acuña C; Represas-Represas C; Lopez-Ramírez C; Fernández VL; Soler-Cataluña JJ; Casamor R;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():975-84. PubMed ID: 26064045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the visit frequency and the use of questionnaires and indices for COPD: a national survey from the On-Sint study.
    López Ramírez C; Calero Acuña C; Represas Represas C; Aballe Santos L; Casamor R; Fernández-Villar A; López-Campos JL
    Clin Respir J; 2017 May; 11(3):367-373. PubMed ID: 26149089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COPD symptom burden: impact on health care resource utilization, and work and activity impairment.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():677-689. PubMed ID: 28260874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [COPD and quality of life: impact of the disease in primary care in France].
    Perez T; Serrier P; Pribil C; Mahdad A
    Rev Mal Respir; 2013 Jan; 30(1):22-32. PubMed ID: 23318186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.